Detalhe da pesquisa
1.
RNase L Suppresses Androgen Receptor Signaling, Cell Migration and Matrix Metalloproteinase Activity in Prostate Cancer Cells.
Int J Mol Sci
; 18(3)2017 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28257035
2.
MDM2 regulates the stability of AR, AR-V7, and TM4SF3 proteins in prostate cancer.
Endocr Oncol
; 4(1): e230017, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38410785
3.
The Transmembrane Protein TM4SF3 Interacts With AR and AR-V7 and is Recruited to AR Target Genes.
Endocrinology
; 164(5)2023 03 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951301
4.
Peptides disrupting TM4SF3 interaction with AR or AR-V7 block prostate cancer cell proliferation.
Endocr Oncol
; 3(1): e230010, 2023 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37822366
5.
Dual-Acting Peptides Target EZH2 and AR: A New Paradigm for Effective Treatment of Castration-Resistant Prostate Cancer.
Endocrinology
; 164(1)2022 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36288553
6.
Androgen up-regulation of Twist1 gene expression is mediated by ETV1.
PeerJ
; 8: e8921, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32296610
7.
c-Jun has multiple enhancing activities in the novel cross talk between the androgen receptor and Ets variant gene 1 in prostate cancer.
Mol Cancer Res
; 5(7): 725-35, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17634427
8.
ETV1 is a novel androgen receptor-regulated gene that mediates prostate cancer cell invasion.
Mol Endocrinol
; 21(8): 1835-46, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17505060
9.
Peptide B targets soluble guanylyl cyclase α1 and kills prostate cancer cells.
PLoS One
; 12(8): e0184088, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28859127
10.
TM4SF3 and AR: A Nuclear Complex that Stabilizes Both Proteins.
Mol Endocrinol
; 30(1): 13-25, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26649804
11.
COP9 subunits 4 and 5 target soluble guanylyl cyclase α1 and p53 in prostate cancer cells.
Mol Endocrinol
; 28(6): 834-45, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24725084
12.
Zinc Finger 280B regulates sGCα1 and p53 in prostate cancer cells.
PLoS One
; 8(11): e78766, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24236047
13.
A peptide against soluble guanylyl cyclase α1: a new approach to treating prostate cancer.
PLoS One
; 8(5): e64189, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23724033
14.
Soluble guanylyl cyclase α1 and p53 cytoplasmic sequestration and down-regulation in prostate cancer.
Mol Endocrinol
; 26(2): 292-307, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22174378
15.
Use of reporter genes to study promoters of the androgen receptor.
Methods Mol Biol
; 590: 195-207, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19763505
16.
Expression of a hyperactive androgen receptor leads to androgen-independent growth of prostate cancer cells.
J Mol Endocrinol
; 41(1): 13-23, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18469090
17.
SUMO-3 enhances androgen receptor transcriptional activity through a sumoylation-independent mechanism in prostate cancer cells.
J Biol Chem
; 281(7): 4002-12, 2006 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-16361251
18.
Makorin RING finger protein 1 (MKRN1) has negative and positive effects on RNA polymerase II-dependent transcription.
Endocrine
; 29(2): 363-73, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16785614
19.
Glycogen synthase kinase-3 beta is involved in the phosphorylation and suppression of androgen receptor activity.
J Biol Chem
; 279(18): 19191-200, 2004 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-14985354